Skip to main content
U2BIO CO., LTD. logo

U2BIO CO., LTD. — Investor Relations & Filings

Ticker · 221800 ISIN · KR7221800006 KO Human health and social work activities
Open in API
Filings indexed 227 across all filing types
Latest filing 2026-04-01 Regulatory Filings
Country KR South Korea
Listing KO 221800

About U2BIO CO., LTD.

https://www.u2bio.co.kr/eng/main.do

U2BIO CO., LTD. is a healthcare technology company specializing in the integration of biotechnology (BT) and information technology (IT). The company provides a range of in vitro diagnostic services, including clinical laboratory tests and molecular diagnostics. Concurrently, it develops and offers digital healthcare solutions and medical IT services tailored for medical institutions such as hospitals and clinics. U2BIO focuses on delivering personalized healthcare services based on scientific data to support medical professionals and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
주요사항보고서(타법인주식및출자증권양수결정)
Regulatory Filings Classification · 85% confidence The document is a Korean “주요사항보고서” disclosing the company’s decision to acquire shares of another entity. It is not an earnings release, dividend notice, management change, share issuance by the company, or own-share repurchase. Nor is it an AGM presentation or full financial report. It is a mandatory regulatory disclosure of a material transaction (investment in another company’s stock), which falls under “Regulatory Filings” as a general fallback for miscellaneous required disclosures to the market.
2026-04-01 Korean
대표이사변경
Board/Management Information Classification · 93% confidence The document is a corporate announcement detailing the change of the company’s 대표이사 (CEO), including before-and-after names, reasons for departure, appointment dates, and related board resolution information. This clearly falls under an announcement of changes in senior management, matching the Board/Management Information category (Code: MANG).
2026-03-31 Korean
본점소재지변경
Regulatory Filings Classification · 75% confidence The document is an official corporate announcement detailing a change of the company’s registered head office address (postal code and physical location), effective dates, board resolution date, and reasoning. It is not a financial report, shareholder vote result, board composition change, or capital transaction. There is no specific category for address changes, so it defaults to a general regulatory announcement category.
2026-03-31 Korean
상호변경안내
Regulatory Filings Classification · 70% confidence The document is a Korean regulatory announcement detailing a company name change (from U2BIO Co., Ltd. to ZGOO Holdings Co., Ltd.), giving reasons, shareholder meeting date, and related notices. It’s not a financial report, earnings release, share issuance, dividend notice, management change, or AGM materials. It does not fit a more specific category and thus falls into the general regulatory filings category.
2026-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 93% confidence The document is a formal notification in Korean titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고,” detailing the appointment, reappointment, dismissal, and mid-term resignation of outside directors. It is submitted to the Financial Services Commission/Korea Exchange and outlines changes in board membership. This falls under announcements of changes to the company’s board of directors or senior management, which corresponds to the Board/Management Information category.
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” (Regular Shareholders’ Meeting Results) and lists detailed vote outcomes for each agenda item (financial statements approval, dividend resolution, statutes amendments, director elections, etc.). This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at an AGM. It is not a notice of report publication, not the report itself, and not other categories such as management changes (MANG) or capital updates (CAP).
2026-03-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.